Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 22

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Simplified lipid II-binding antimicrobial peptides: Design, synthesis and antimicrobial activity of bioconjugates of nisin rings A and B with pore-forming peptides

Mitchell, Serena A., Truscott, Fiona, Dickman, Rachael, Ward, John, Tabor, Alethea B.·2018·Bioorganic & Medicinal Chemistry
DOI 10.1016/j.bmc.2018.10.015
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bmc.2018.10.015

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 58

  1. Blaskovich, 2017, Polishing the tarnished silver bullet: the quest for new antibiotics, Essays Biochem, 61, 103, 10.1042/EBC20160077 · DOI
  2. Gilbert, 2010, The 10 × ‘20 initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020, Clin Infect Dis, 50, 1081, 10.1086/652237 · DOI · Paper page
  3. Moloney, 2016, Trends Pharmacol Sci, 37, 1
  4. Aguirre, 2016, Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials, Adv Drug Deliv Rev, 106, 223, 10.1016/j.addr.2016.02.004 · DOI · Paper page
  5. Chatterjee, 2005, Biosynthesis and mode of action of lantibiotics, Chem Rev, 105, 633, 10.1021/cr030105v · DOI · Paper page
  6. Wilson-Stanford, 2009, Oxidation of lanthionines renders the lantibiotic nisin inactive, Appl Environ Microbiol, 75, 1381, 10.1128/AEM.01864-08 · doi:10.1128/aem.01864-08
  7. Chan, 1996, Structure-activity relationships in the peptide antibiotic nisin: Role of dehydroalanine 5, Appl Environ Microbiol, 62, 2966, 10.1128/aem.62.8.2966-2969.1996 · doi:10.1128/aem.62.8.2966-2969.1996
  8. Rollema, 1995, Improvement of solubility and stability of the antimicrobial peptide nisin by protein engineering, Appl Environ Microbiol, 61, 2873, 10.1128/aem.61.8.2873-2878.1995 · DOI · Paper page
  9. Suda, 2010, Effect of bioengineering lacticin 3147 lanthionine bridges on specific activity and resistance to heat and proteases, Chem Biol, 17, 1151, 10.1016/j.chembiol.2010.08.011 · DOI
  10. Bernbom, 2006, Effects of Lactococcus lactis on composition of intestinal microbiota: role of nisin, Appl Environ Microbiol, 72, 239, 10.1128/AEM.72.1.239-244.2006 · DOI
  11. Fox, 2013, Antimicrobial peptides stage a comeback, Nat Biotechnol, 31, 379, 10.1038/nbt.2572 · DOI · Paper page
  12. Delves-Broughton, 1990, Nisin and its application as a food preservative, Int J Dairy Technol, 43, 73, 10.1111/j.1471-0307.1990.tb02449.x · DOI · Paper page
  13. Zhou, 2014, Mechanisms of nisin resistance in Gram-positive bacteria, Ann Microbiol, 64, 413, 10.1007/s13213-013-0679-9 · DOI
  14. Breukink, 2006, Lipid II as a target for antibiotics, Nat Rev Drug Discov, 5, 321, 10.1038/nrd2004 · DOI · Paper page
  15. Ng, 2016, New found hope for antibiotic discovery: lipid II inhibitors, Chem Eur J, 22, 12606, 10.1002/chem.201601315 · DOI
  16. Hsu, 2004, The nisin-lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics, Nat Struct Mol Biol, 11, 963, 10.1038/nsmb830 · DOI · Paper page
  17. Chan, 1996, Structure-activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin, FEBS Lett, 390, 129, 10.1016/0014-5793(96)00638-2 · doi:10.1016/0014-5793(96)00638-2
  18. Koopmans, 2015, Semisynthetic lipopeptides derived from nisin display antibacterial activity and lipid II binding on par with that of the parent compound, J Am Chem Soc, 137, 9382, 10.1021/jacs.5b04501 · DOI
  19. Hasper, 2004, Assembly and stability of nisin-lipid II pores, Biochemistry, 43, 11567, 10.1021/bi049476b · DOI · Paper page
  20. Kuipers, 1996, Protein engineering of lantibiotics, Antoine van Leeuwenhoek, 69, 161, 10.1007/BF00399421 · DOI
  21. Healy, 2013, Intensive mutagenesis of the nisin hinge leads to the rational design of enhanced derivatives, PLoS ONE, 8, 10.1371/journal.pone.0079563 · DOI
  22. Zhou, 2015, The length of a lantibiotic hinge region has profound influence on antimicrobial activity and host specificity, Front Microbiol, 6, 11, 10.3389/fmicb.2015.00011 · DOI
  23. Field, 2010, Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V, Microb Biotechnol, 3, 473, 10.1111/j.1751-7915.2010.00184.x · DOI
  24. Fukase, 1992, Synthetic study on peptide antibiotic nisin. V. Total synthesis of nisin, Bull Chem Soc Jpn, 65, 2227, 10.1246/bcsj.65.2227 · doi:10.1246/bcsj.65.2227
  25. Bregant, 2005, Orthogonally protected lanthionines: synthesis and use for the solid-phase synthesis of an analogue of nisin ring C, J Org Chem, 70, 2430, 10.1021/jo048222t · doi:10.1021/jo048222t
  26. Mothia, 2011, Synthesis of peptides containing lanthionine bridges on the solid phase: an analogue of rings D and E of the lantibiotic nisin, Org Lett, 13, 4216, 10.1021/ol201548m · doi:10.1021/ol201548m
  27. Harmsen, 2014, A conformationally constrained fused tricyclic nisin AB-ring system mimic toward an improved pyrophosphate binder of lipid II, Tetrahedron, 70, 7691, 10.1016/j.tet.2014.06.023 · doi:10.1016/j.tet.2014.06.023
  28. Ghalit, 2005, Ring-closing alkyne metathesis approach toward the synthesis of alkyne mimics of thioether A-, B-, C-, and DE-ring systems of the lantibiotic nisin Z, Org Lett, 7, 2961, 10.1021/ol0508781 · doi:10.1021/ol0508781
  29. Slootweg, 2015, Synthesis of nisin AB dicarba analogs using ring-closing metathesis: influence of sp3 versus sp2 hybridization of the α-carbon atom of residues dehydrobutyrine-2 and dehydroalanine-5 on the lipid II binding affinity, Org Biomol Chem, 13, 5997, 10.1039/C5OB00336A · doi:10.1039/c5ob00336a
  30. Manzor, 2017, Solid-phase peptide synthesis of analogues of the N-terminus A-ring fragment of the lantibiotic nisin: replacements for the dehydroalanine (Dha) residue at position 5 and the first incorporation of a thioamide residue, Tetrahedron Lett, 58, 2959, 10.1016/j.tetlet.2017.06.052 · doi:10.1016/j.tetlet.2017.06.052
  31. Liu, 2011, Solid supported chemical syntheses of both components of the lantibiotic lacticin 3147, J Am Chem Soc, 133, 14216, 10.1021/ja206017p · doi:10.1021/ja206017p
  32. Ross, 2010, Synthesis of the lantibiotic lactocin S using peptide cyclizations on solid phase, J Am Chem Soc, 132, 462, 10.1021/ja9095945 · doi:10.1021/ja9095945
  33. Tabor, 2011, The challenge of the lantibiotics: synthetic approaches to thioether-bridged peptides, Org Biomol Chem, 9, 7606, 10.1039/c1ob05946g · doi:10.1039/c1ob05946g
  34. Escano, 2015, Multipronged approach for engineering novel peptide analogues of existing lantibiotics, Expert Opin Drug Discovery, 10, 857, 10.1517/17460441.2015.1049527 · DOI
  35. Sandiford, 2015, Perspectives on lantibiotic discovery – where have we failed and what improvements are required?, Expert Opin Drug Discovery, 10, 315, 10.1517/17460441.2015.1016496 · DOI
  36. Tabor, 2014, Recent advances in synthetic analogues of lantibiotics: what can we learn from these?, Bioorg Chem, 55, 39, 10.1016/j.bioorg.2014.04.004 · DOI
  37. Arnusch, 2008, The vancomycin-nisin (1–12) hybrid restores activity against vancomycin resistant enterococci, Biochemistry, 47, 12661, 10.1021/bi801597b · DOI
  38. Arnusch, 2012, Enhanced membrane pore formation through high-affinity targeted antimicrobial peptides, PLoS ONE, 7, 10.1371/journal.pone.0039768 · doi:10.1371/journal.pone.0039768
  39. Slootweg, 2014, Semi-synthesis of biologically active nisin hybrids composed of the native lanthionine ABC-fragment and a cross-stapled synthetic DE-fragment, Bioorg Med Chem, 22, 5345, 10.1016/j.bmc.2014.07.046 · DOI
  40. Zhou, 2016, Potentiating the activity of nisin against Escherichia coli, Front Cell Dev Biol, 4, 7, 10.3389/fcell.2016.00007 · DOI
  41. Valverde, 2013, 1,2,3-Triazoles as amide bond mimics: triazole scan yields protease-resistant peptidomimetics for tumor targeting, Angew Chem Int Ed, 52, 8957, 10.1002/anie.201303108 · DOI · Paper page
  42. Souza, 2005, Structural and functional characterization of two novel peptide toxins isolated from the venom of the social wasp Polybia paulista, Peptides, 26, 2157, 10.1016/j.peptides.2005.04.026 · DOI · Paper page
  43. Cabrera, 2008, Selectivity in the mechanism of action of antimicrobial mastoparan peptide Polybia-MP1, Eur Biophys J, 37, 879, 10.1007/s00249-008-0299-7 · doi:10.1007/s00249-008-0299-7
  44. Ge, 1999, In vitro antibacterial properties of pexiganan, an analog of magainin, Antimicrob Agents Chemother, 43, 782, 10.1128/AAC.43.4.782 · DOI · Paper page
  45. Porcelli, 2006, Structures of the dimeric and monomeric variants of magainin antimicrobial peptides (MSI-78 and MSI-594) in micelles and bilayers, determined by NMR, Biochemistry, 45, 5793, 10.1021/bi0601813 · DOI · Paper page
  46. Hallock, 2003, MSI-78, an analogue of the magainin antimicrobial peptides, disrupts lipid bilayer structure via positive curvature strain, Biophys J, 84, 3052, 10.1016/S0006-3495(03)70031-9 · DOI · Paper page
  47. Simon, 1992, Peptoids: a modular approach to drug discovery, Proc Natl Acad Sci USA, 89, 9367, 10.1073/pnas.89.20.9367 · DOI · Paper page
  48. Chongsiriwatana, 2008, Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides, Proc Natl Acad Sci USA, 105, 2794, 10.1073/pnas.0708254105 · DOI · Paper page
  49. Hamley, 2014, PEG-peptide conjugates, Biomacromolecules, 15, 1543, 10.1021/bm500246w · DOI · Paper page
  50. Slootweg, 2013, Scalable purification of the lantibiotic nisin and isolation of chemical/enzymatic cleavage fragments suitable for semi-synthesis, J Pept Sci, 19, 692, 10.1002/psc.2551 · doi:10.1002/psc.2551
  51. Slootweg, 2013, Synthesis, antimicrobial activity, and membrane permeabilizing properties of C-terminally modified nisin conjugates accessed by CuAAC, Bioconjugate Chem, 24, 2058, 10.1021/bc400401k · doi:10.1021/bc400401k
  52. Rink, 1987, Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resin, Tetrahedron Lett, 28, 3787, 10.1016/S0040-4039(00)96384-6 · DOI · Paper page
  53. Patch, 2003, Helical peptoid mimics of magainin-2 amide, J Am Chem Soc, 125, 12092, 10.1021/ja037320d · DOI · Paper page
  54. Chan, 2004, Polytriazoles as copper(I)-stabilizing ligands in catalysis, Org Lett, 6, 2853, 10.1021/ol0493094 · DOI · Paper page
  55. Bolt, 2018, Synthesis of antibacterial nisin-peptoid hybrids using click methodology, Molecules, 23, 10.3390/molecules23071566 · doi:10.3390/molecules23071566
  56. Medeiros-Silva, 2018, High-resolution NMR studies of antibiotics in cellular membranes, Nat Commun, 9, 3963, 10.1038/s41467-018-06314-x · DOI
  57. Cornish, 1999, Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes, Am J Physiol, 277, E779
  58. Wiegand, 2008, Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances, Nat Protoc, 3, 163, 10.1038/nprot.2007.521 · DOI · Paper page

Cited by

See all 22

Metadata

Authors
Mitchell, S. A., Truscott, F., Dickman, R., Ward, J., & Tabor, A. B.
Venue
Bioorganic & Medicinal Chemistry
Publisher
Elsevier BV
Published
2018-11
Volume
26
Issue
21
Pages
5691-5700
ISSN
0968-0896
DOI
10.1016/j.bmc.2018.10.015
Cited by
22
References
1
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Simplified lipid II-binding antimicrobial peptides: Design, synthesis and antimicrobial activity of bioconjugates of nisin rings A and B with pore-forming peptides. https://app.cochat.ai/papers/10.1016/j.bmc.2018.10.015
The paper
Mitchell, S. A., Truscott, F., Dickman, R., Ward, J., & Tabor, A. B. (2018). Simplified lipid II-binding antimicrobial peptides: Design, synthesis and antimicrobial activity of bioconjugates of nisin rings A and B with pore-forming peptides. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2018.10.015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.